Edgewise Therapeutics (EWTX) is the lead sponsor of 7 active clinical trials listed on ClinicalTrials.gov[3], including 5 Phase 2[1], 2 Phase 1[2].
Edgewise Therapeutics (EWTX) is the lead sponsor of 7 active clinical trials listed on ClinicalTrials.gov[3], including 5 Phase 2[1], 2 Phase 1[2].